chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My son had a generalized tonic clonic seizure that lasted 14 minutes and required 2 doses of medication to stop it.
pt recv vax 19JUN97 & 22JUN97 pt devel a fever of 104 which persisted for 4 days;23JUN97 pt exp febrile, purpuric rash on rt forearm involving the hand up to the elbow;pharyngitis w/red swelling & white infiltrate;OM;allerg;
received vaccine c/o pain at time of injection same day evening c/o warmth, pain, tenderness. Increased temp in area. On 6/4/01 returned to clinic - R deltoid area warm to touch, c/o tenderness pain, swelling. Received warm/cold compresses. Move arm
Extremely painful arm and shoulder with swelling and redness.  Flu-like symptoms chills/fever, body achiness, headache, weakness, loss of appetite, red rash on chest.
Arm is numb from top left shoulder, also having mild pulling pain in surrounding around the injection site on left arm. I have tingling sensation in all 5 fingertips of my left hand. The pains and sensations come & go periodically throughout a 24 hour period
it started itchin/itching is feeling now like she's breaking out in way ups all over her body/She states it started in her arm, then started in the lower part of legs, and her stomach; had itchy skin; The doctors stated it could be a reaction from the Covid vaccine; achy; ran a fever for like 3 days; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (it started itchin/itching is feeling now like she's breaking out in way ups all over her body/She states it started in her arm, then started in the lower part of legs, and her stomach), PRURITUS (had itchy skin), VACCINATION COMPLICATION (The doctors stated it could be a reaction from the Covid vaccine), MYALGIA (achy) and PYREXIA (ran a fever for like 3 days) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03021A and 023M209) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (it started itchin/itching is feeling now like she's breaking out in way ups all over her body/She states it started in her arm, then started in the lower part of legs, and her stomach), PRURITUS (had itchy skin), VACCINATION COMPLICATION (The doctors stated it could be a reaction from the Covid vaccine), MYALGIA (achy) and PYREXIA (ran a fever for like 3 days). The patient was treated with HYDROCORTISONE for Itching, at an unspecified dose and frequency and PREDNISONE for Itching, at a dose of 20 milligram. At the time of the report, PRURITUS (it started itchin/itching is feeling now like she's breaking out in way ups all over her body/She states it started in her arm, then started in the lower part of legs, and her stomach), PRURITUS (had itchy skin), VACCINATION COMPLICATION (The doctors stated it could be a reaction from the Covid vaccine), MYALGIA (achy) and PYREXIA (ran a fever for like 3 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that itching started a week after vaccine and didn't stopped even after taking hydrocortisone and prednisone. No concomitant medication reported.
Patient presented to the ED and was subsequently admitted within 6 weeks of receiving COVID vaccination. Diagnosis was bilateral pulmonary embolism.
Information has been received from a nurse via a field service representative referring to a 5 or 6 years old male patient. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 23-AUG-2016, the patient was vaccinated with a dose of M-M-R II (strength, dose, frequency, lot number and expiration date were unknown) subcutaneously. It was reported that the kindergarten age child had been vaccinated with M-M-R II, but might have developed mumps in 2016. The outcome of the events was unknown. Additional information has been requested.
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Poor quality vaccine administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    Concomitant product use was not provided by the reporter. It was reported there was a temperature excursion between 26 May 2022 to 30 Sep 2022 and lot AR5186C was affected between 08 Sep 2022 to 27 Sep 2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 01-Aug-2022 and individual vials were put in the refrigerator on the day of use. No treatment information was provided. This case contains information for the 55th of 104 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:Same reporter
Lightheaded and dizziness; Blood pressure was elevated; Anxiety; This is a spontaneous report from a contactable pharmacist. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via intramuscular route of administration in the left arm on 14Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included transient ischaemic attack (TIA). The patient had known allergies to sulfa antibiotics and avocados. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included lorazepam (ATIVAN); taken for an unknown indication from an unknown date and unknown if ongoing. On 14Apr2021, the patient reported lightheaded and dizziness, blood pressure was elevated. The patient reported improvement of symptoms. Education was provided for blood pressure and anxiety. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On 14Apr2021, the patient underwent blood pressure test and the result was elevated. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events lightheaded and dizziness, blood pressure was elevated and anxiety was resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Fever, Headache, Nausea lasted 36 hrs, unable to eat normally for 4 days
Upon receiving dose 1 of the COVID-19 Pfizer vaccine, patient shortly afterwards began to c/o of numbness to the mouth and having a scratchy throat. A Person In Distress was called overhead, where staff and the physician on-duty wheeled the patient into a treatment room. After an IV line was secured, patient was given 25 mg Benadryl IVP, 500 mL of NS, along with receiving an Epi pen 0.3 IM. Patient responded well, and was ultimately transported by Paramedics to the ED for further evaluation.
03/25/2021 at around 06:00PM my left ear started ringing. First 9 months it stayed the same level of ringing. It was a medium pitched ringing. I called my doctor and he referred me to 2 ENT doctors. Its still there. I saw 2 ENT doctors the first one said it was ok but I lost 20% of my hearing. The second one said the same thing. I lost 15-20% on my left ear. I really not sure but it all started happening after my second dose. I still experience the ringing in my left ear little less, its never gone. I still have it.
Father brought daughter saying she was receiving her first dose.  It wasn't until I was uploading database did I realize she already received 2 previous doses of Pfizer.  Father misinformed us in order to get his daughter a booster dose.
Pt was given first dose of Moderna  0.5 for kids 6mos to 5Y?? Pt notified and  no effects noted .
This spontaneous case, initially received from pharmacist on 24-Oct-2018, concerns a 69-year-old, elderly male patient. The patient had no medical history and concomitant medications. On 10-Oct-2018, the patient was administered the partial dose FLUAD (TIV) [dose: less than 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 250783 and expiry date: 30-Apr-2019] (explicitly coded as incomplete dose administered). It was reported that the patient did not receive full dose because the vaccine came out and the patient's arm got exposed to some vaccine (explicitly coded as exposure via skin contact). On 09-Nov-2018, the patient was revaccinated with unspecified vaccine (dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) (explicitly coded as drug administration error). No adverse events were experienced after vaccination and no treatment measures were required. The reporter assessed this case as non-serious. Follow-up report received from the pharmacist on 21-Nov-2018: It was reported that, the patient was revaccinated with unspecified vaccine. The event (drug administration error) was added in the event tab. Reporter confirmed that, some of the vaccine contacted the patient's arm but had no reactions. Narrative was amended accordingly.
I been getting really bad cramps but I don't get my period; I don't get my period this has never happen; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (I been getting really bad cramps but I don't get my period) and AMENORRHOEA (I don't get my period this has never happen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (I been getting really bad cramps but I don't get my period) and AMENORRHOEA (I don't get my period this has never happen). At the time of the report, MUSCLE SPASMS (I been getting really bad cramps but I don't get my period) and AMENORRHOEA (I don't get my period this has never happen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Patient says patient developed rash in left arm. unknown time and date on development on rash. Patient couldn't remember.  initially reported on 10/22/2019 to pharmacy. Per patient, it was quarter size rash on left arm. Patient has been putting neosporin on but wasn't able to resolve rash for few weeks. We notified patient to contact the doctor. According to patient on 10/23/2019, doctor prescribed antibiotic ointment.
sore arm; it started itching; hives; Malaise; tired; one part of her body then stopped, then another part of her body and then stopped; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise) and FATIGUE (tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure (High blood pressure.). Concomitant products included CELECOXIB (CELEBREX), CELECOXIB, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and MONTELUKAST for an unknown indication, MONTELUKAST SODIUM (SINGULAIR).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were high blood pressure medications. Treatment medications taken were Benadryl and applied lotion.
Left arm pain for 24hrs post dose. Extreme knee and ankle joint pain. Low grade fever of 99.5 accompanied by periods of shivering.  Sinus pressure and headache. Symptoms resolved after two doses of ibuprofen
administered expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) in a 43-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. The vial did not undergo temperature excursion and it was unknown when the vial was initially stored in the refrigerator. Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received contains Non significant information.
pt recvd vax & w/in 5 hrs post vax pt exp nausea,vomiting,& diarrhea;these sx subsided w/o treatment;
This spontaneous report as received from a nurse via a company representative refers to an about 17 or 18 years old male patient. The patient was a fraternal twin. There was no information about the patient's concurrent conditions, any known allergies or reaction, medical history or concomitant medications. On an unknown date, the patient was vaccinated with an unspecified dose of GARDASIL or GARDASIL 9, for prevent human papillomavirus (HPV) (dose, route of administration, lot number and expiration date were not reported).  On an unknown date, after received the vaccine, the patient experienced Tourette's (Tourette's disorder). It was unknown if the patient sought medical attention, treatment was given for the adverse event or laboratory diagnostics studies were performed. The outcome of Tourette's disorder and the causal relationship between the event and therapy with GARDASIL or GARDASIL 9 were not reported. No product quality complaint was involved. Upon internal review the event Tourette's disorder was considered to be medically significant. This is one of two reports received from the same reporter. Additional information is not expected because the reporter did not consent for further follow up.; Sender's Comments: US-009507513-1706USA006825:
Pt given flu vaccine in right deltoid, 2 days later mom noticed site swollen, red, hot and painful to touch, gave a dose of BENADRYL with little improvement - seen in office on 11/9/17 and dx with cellulitis - given abx.
Two months after vaccine started feeling dull tooth pain every 30 seconds on and off for a half hour; After 40 minutes back of chest started hurting; Went to urgent care and was given an EKG, chest X-ray and had blood work; No findings.
Patient's mother did not want child to have a multi-dose injection. Provider told nursing staff it was ok to give Tdap being that she already has had a tetanus dose in the past. Nursing staff asked to verify if this was correct. Provider ordered vaccine and vaccine was given. Patient's mother was notified that this vaccine is for 7 years and older and mother stated it was ok. No treatment/outcomes.
This patient was admitted to Hospital on 1/30/2022 for COVID related symptoms. This is considered a breakthrough case.
This spontaneous report was received from a 60 years old female consumer reporting on herself with no pertinent medical history, drug reactions or allergies. The patient was vaccinated with ZOSTAVAX on 05-DEC-2012. No other co-suspects were reported. There were no concomitant medications. The consumer reported that on 06-DEC-2012 she had itching sensation where the shot was given and also some redness on the arm. It was unknown if the patient sought medical attention. No treatment was given for the event. The outcome of itching sensation where the shot was given and some redness on the arm was unknown. The relatedness for the reported events was not provided for ZOSTAVAX. Additional information is not expected.
daughter was exposed to sibling who recv vax SEP97 & 14OCT97 pt devel chickenpox (approx 15 lesions) & a dry hacking cough;
Tiredness, chills, joint pain, injection site redness, feeling unwell; difficulty breathing at times, dizziness and weakness. Still on going event. Went to doctor. See below
Pt awoke in the morning with right upper arm swollen, warm, localized muscle tissue of warmth at injection site and severe pain. Symptoms remained localized as of Monday 03/20 at 8:45. Alternated heat and ice application at injection site. Tylenol and Motrin still being taken PRN. Could not move right arm Friday evening. Advised to see physician. She will phone post appointment. As of 04/03, right arm pain remains.
Fever, sweats, redness, swelling around site for 2 days. Visible redness today.
104-105 fevers, chills, shortness of breath, migraine, fatigue, muscle and joint pain, lymph node swelling
Patient tested positive 11/23 for COVID at skilled nursing facility. Admitted to the hospital 11/26/2022. Patient expired 11/28
She states that she got a cold sore 7 days after she received the immunization - this happened with both shots in the series.
headache, chills and muscle pain and a slight dizziness; headache, chills and muscle pain and a slight dizziness; headache, chills and muscle pain and a slight dizziness; headache, chills and muscle pain and a slight dizziness; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Lot: Ek9231 via an unspecified route of administration on 24Dec2020 at 10:00 (at the age of 57-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included an allergy to sulfa drugs as of an unspecified date and unknown if ongoing; Covid-19 diagnosed prior to the vaccination on 24Nov (year unspecified) and not ongoing (patient had recovered from COVID, was sick and quarantined until 04Dec (year unspecified)). The patient was not pregnant at the time of vaccination. Concomitant medications included calcium carbonate/colecalciferol (CALCIUM & VITAMIN D3), garlic [allium sativum], omeprazole magnesium (PRILOSEC), ascorbic acid (VIT C) and an unspecified multi-vitamin; all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. The patient previously took meloxicam and doxycycline; all from unknown dates to unknown dates for unknown indications and experienced allergy. On 24Dec2020 at 23:00 (reported as later in the evening), the patient experienced headache, chills, muscle pain and a slight dizziness. The patient did not receive treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the headache, chills, muscle pain and a slight dizziness were resolving.
Right deltoid pain day after receiving vaccination, difficulty moving arm with pain.  No swelling, no redness, no fever.  Able to move distal fingers.
Patient was given Pentacel but should have been given Hib only.  Immunization Program was called and they said that no harm in patient receiving the "extra" doses of Dtap and Polio) and to keep an eye on patient's symptoms in terms of typical vaccine side effects. Patient's mother informed.
Information has been received from a mother concerning her 12 month old son who has no pertinent medical history and from a physician who confirmed that the 12 month old male pt on 25JUN2003 was vaccinated SC with a 0.5ml dose of varicella virus vaccine live. There was no concomitant medication. The mother reported that within a "day or so" (approximately 26JUN2003) the pt developed a 104 degree fever. It was noted that the child was given acetaminophen and ibuprofen to treat the fever. It was noted that the fever lasted 6 days and on the seventh day, his temperature began to return to normal. There was no product quality complaint reported. The physician reported, "the pt needs the measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live and the mother is concerned about the child getting a fever again. Unspecified medical attention was sought. Additional information has been requested.
chills, h/a, inc BP, inc pulse;back pain all sx lasting 5hr;